Viral-based individualized neoantigen vaccine as adjuvant treatment in resected head and neck squamous cell carcinoma: immunogenicity and efficacy from a randomized Phase I trial

C. Ottensmeier, et al.
medRxiv
Preprint available on medRxiv website – Download the Article